Medscape2y
Iliac Artery Revascularization
The incidence of target-lesion revascularization was 6.5, 9.0, and 10.2% at 6, 12 and 24 months, respectively. The MELODIE trial also demonstrated the safety of iliac artery revascularization with ...
Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment
PRNewswire Tampa Florida [US] January 7 Concept Medical Inc a global leader in innovative drug-delivery technology proudly ...
Nature4y
Successful coronary scaffolding achieved with bioabsorbable stents
The overall rate of ischemia-driven target lesion revascularization was 23.8% at 4 months' and 26.7% at 12 months' follow-up. Further development of absorbable stents is underway, and larger scale ...
Nature22d
Does stent overlap make a difference to clinical outcome?
The use of drug-eluting stents (DES) has become widespread as a result of their superior revascularization rates compared with those of bare-metal stents (BMS). 1 DES are increasingly being used ...
Medscape3y
Iliac Artery Revascularization
There was no statistically significant difference in the 9-month composite end point of restenosis rate, perioperative death or target lesion revascularization between the two groups. The 12-month ...